Soluble Suppression of Tumorigenicity‐2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device

Background Soluble suppression of tumorigenicity‐2 (sST2) predicts mortality in patients with heart failure. The predictive value of sST2 in patients with a left ventricular assist device remains unknown. Therefore, we studied the relationship between sST2 and outcome after left ventricular assist d...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Lieke Numan, Emmeke Aarts, Faiz Ramjankhan, Marish I. F. Oerlemans, Manon G. van der Meer, Nicolaas de Jonge, Anne‐Marie Oppelaar, Hans Kemperman, Folkert W. Asselbergs, Linda W. Van Laake
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Wiley 2024-01-01
Цуврал:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Нөхцлүүд:	end‐stage heart failure left ventricular assist device right heart failure soluble suppression of tumorigenicity‐2
Онлайн хандалт:	https://www.ahajournals.org/doi/10.1161/JAHA.123.029827
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!